Generics in Mexico
Generics in Mexico
SUMMARY
Generics in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Mexican generics market had total revenues of $6.6bn in 2019, representing a compound annual growth rate (CAGR) of 9.9% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 1.4% between 2015 and 2019, to reach a total of 91.9% in 2019.
- A growing middle class and better access to health care services are greatly increasing consumer demand for pharmaceutical products, including generics, in Mexico.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Mexico
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Mexico
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Mexico generics market with five year forecasts by both value and volume
- What was the size of the Mexico generics market by value in 2019?
- What will be the size of the Mexico generics market in 2024?
- What factors are affecting the strength of competition in the Mexico generics market?
- How has the market performed over the last five years?
- How large is Mexico’s generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Sun Pharmaceutical Industries Ltd
8.3. Teva Pharmaceutical Industries Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Sun Pharmaceutical Industries Ltd
8.3. Teva Pharmaceutical Industries Limited
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Mexico generics market value: $ million, 2015-19
Table 2: Mexico generics market volume: % of total pharma, 2015-19
Table 3: Mexico generics market geography segmentation: $ million, 2019
Table 4: Mexico generics market value forecast: $ million, 2019-24
Table 5: Mexico generics market volume forecast: % of total pharma, 2019-24
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Sun Pharmaceutical Industries Ltd: key facts
Table 11: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 12: Sun Pharmaceutical Industries Ltd: Key Employees
Table 13: Teva Pharmaceutical Industries Limited: key facts
Table 14: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 15: Teva Pharmaceutical Industries Limited: Key Employees
Table 16: Mexico size of population (million), 2015-19
Table 17: Mexico gdp (constant 2005 prices, $ billion), 2015-19
Table 18: Mexico gdp (current prices, $ billion), 2015-19
Table 19: Mexico inflation, 2015-19
Table 20: Mexico consumer price index (absolute), 2015-19
Table 21: Mexico exchange rate, 2015-19
Table 1: Mexico generics market value: $ million, 2015-19
Table 2: Mexico generics market volume: % of total pharma, 2015-19
Table 3: Mexico generics market geography segmentation: $ million, 2019
Table 4: Mexico generics market value forecast: $ million, 2019-24
Table 5: Mexico generics market volume forecast: % of total pharma, 2019-24
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Sun Pharmaceutical Industries Ltd: key facts
Table 11: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 12: Sun Pharmaceutical Industries Ltd: Key Employees
Table 13: Teva Pharmaceutical Industries Limited: key facts
Table 14: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 15: Teva Pharmaceutical Industries Limited: Key Employees
Table 16: Mexico size of population (million), 2015-19
Table 17: Mexico gdp (constant 2005 prices, $ billion), 2015-19
Table 18: Mexico gdp (current prices, $ billion), 2015-19
Table 19: Mexico inflation, 2015-19
Table 20: Mexico consumer price index (absolute), 2015-19
Table 21: Mexico exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Mexico generics market value: $ million, 2015-19
Figure 2: Mexico generics market volume: % of total pharma, 2015-19
Figure 3: Mexico generics market geography segmentation: % share, by value, 2019
Figure 4: Mexico generics market value forecast: $ million, 2019-24
Figure 5: Mexico generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Mexico, 2019
Figure 7: Drivers of buyer power in the generics market in Mexico, 2019
Figure 8: Drivers of supplier power in the generics market in Mexico, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Mexico, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Mexico, 2019
Figure 1: Mexico generics market value: $ million, 2015-19
Figure 2: Mexico generics market volume: % of total pharma, 2015-19
Figure 3: Mexico generics market geography segmentation: % share, by value, 2019
Figure 4: Mexico generics market value forecast: $ million, 2019-24
Figure 5: Mexico generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Mexico, 2019
Figure 7: Drivers of buyer power in the generics market in Mexico, 2019
Figure 8: Drivers of supplier power in the generics market in Mexico, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Mexico, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Mexico, 2019